Final Thoughts on Vasomotor Symptoms and NK Receptor Antagonism

The panel reflects on how NK receptor science has transformed the understanding of menopausal physiology and expanded therapeutic possibilities. By targeting the neural origins of VMS, these agents redefine symptom management beyond hormonal dependence.

They stress that education and awareness remain crucial—both for clinicians and patients—to overcome misconceptions and ensure informed adoption of these therapies. With continued research and post-market experience, these agents could become foundational in menopause care.

The conversation concludes on an optimistic note, emphasizing innovation, collaboration, and compassion in advancing quality of life for menopausal patients.